Sign up to save your podcasts
Or
Share Q3 earnings recap: Winners, losers & surprises
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Q3 earnings recap: Winners, losers & surprises
This week (our inaugural episode!) BioSpace's Greg Slabodkin, Tyler Patchen and Lori Ellis discuss the good, the bad and the ugly of biopharma's reported Q3 earnings. They also tackle what's going on at Pfizer, ADCs, deals and more.
Want to dive deeper on BioSpace? Read more on Pfizer's recent cuts as part of their cost-savings program and more insight on Q3 earnings for Gilead, Novo Nordisk, Moderna, Vertex, BMS, Lilly, GSK.
Meanwhile, industry-wide layoffs march on and in case you missed it - bankruptcies reached a record high.
View all episodes
By BioSpace
4.9
1313 ratings
This week (our inaugural episode!) BioSpace's Greg Slabodkin, Tyler Patchen and Lori Ellis discuss the good, the bad and the ugly of biopharma's reported Q3 earnings. They also tackle what's going on at Pfizer, ADCs, deals and more.
Want to dive deeper on BioSpace? Read more on Pfizer's recent cuts as part of their cost-savings program and more insight on Q3 earnings for Gilead, Novo Nordisk, Moderna, Vertex, BMS, Lilly, GSK.
Meanwhile, industry-wide layoffs march on and in case you missed it - bankruptcies reached a record high.
More shows like BioSpace
View all
This American Life
91,086 Listeners
Planet Money
30,757 Listeners
Hidden Brain
43,552 Listeners
Marketplace
8,794 Listeners
Exchanges
979 Listeners
WSJ What’s News
4,401 Listeners
Bloomberg Surveillance
1,188 Listeners
Odd Lots
2,003 Listeners
Up First from NPR
56,945 Listeners
The Indicator from Planet Money
9,560 Listeners
The Readout Loud
339 Listeners
The Journal.
6,120 Listeners
Short Wave
6,577 Listeners
BioCentury This Week
34 Listeners
Biotech Hangout
19 Listeners